Filing Details

Accession Number:
0001209191-23-012765
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-24 16:57:39
Reporting Period:
2023-02-22
Accepted Time:
2023-02-24 16:57:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1571949 Intercontinental Exchange Inc. ICE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1343882 C Jeffrey Sprecher 5660 New Northside Drive
Atlanta GA 30328
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-02-22 70,441 $41.59 1,284,931 No 4 M Direct
Common Stock Disposition 2023-02-22 69,636 $103.95 1,215,295 No 4 S Direct
Common Stock Disposition 2023-02-22 12,191 $104.39 1,203,104 No 4 S Direct
Common Stock Disposition 2023-02-22 26,232 $103.96 2,945,473 No 4 S Indirect CPEX
Common Stock Disposition 2023-02-22 3,768 $104.40 2,941,705 No 4 S Indirect CPEX
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect CPEX
No 4 S Indirect CPEX
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Holding Disposition 2023-02-22 70,441 $0.00 70,441 $41.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
140,884 2025-01-20 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 81,570 Indirect By spouse
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.
  2. The price range for the aggregate amount sold by the direct holder is $103.29 - $104.28. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  3. The price range for the aggregate amount sold by the direct holder is $104.29 - $104.60. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. The common stock number referred in Table I is an aggregate number and represents 1,161,719 shares of common stock and 41,385 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.
  5. The price range for the aggregate amount sold by the direct holder is $103.31 - $104.30. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  6. The price range for the aggregate amount sold by the direct holder is $104.31 - $104.58. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  7. As previously reported, the reporting person also indirectly owns 2,941,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
  8. As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
  9. These options are fully vested.